CME Group (CME) Stock Price Target Upped at Jefferies

CME Group’s (CME) stock price target was raised to $112 from $104 at Jefferies on Tuesday.
By Kaya Yurieff ,

NEW YORK (TheStreet) -- CME Group's (CME) - Get Report stock price target was boosted to $112 from $104 at Jefferies on Tuesday. The firm has a "buy" rating on the stock.

"Generally volumes for most asset classes declined quarter-over-quarter but grew year-over-year led by U.S. equities and options. Within futures, energy volumes continue to be strong while interest rates were down. Overall the group has benefited from the increase in macro volatility," Jefferies wrote in an analyst note.

CME and Intercontinental Exchange (ICE) remain the firm's "favorite ideas" over the next 12 months.

Additionally, Jefferies raised its 2016 second quarter earnings per share estimate for CME by 3 cents to $1.12 to reflect a positive product mix shift in volumes.

The futures company is one of the largest options and futures exchanges.

Shares of CME closed higher by 0.4% to $99.76 on Tuesday.

Separately, TheStreet Ratings Team has a "Buy" rating with a score of A+ on the stock.

The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, increase in net income, reasonable valuation levels and expanding profit margins.

Recently, TheStreet Ratings objectively rated this stock according to its "risk-adjusted" total return prospect over a 12-month investment horizon. Not based on the news in any given day, the rating may differ from Jim Cramer's view or that of this articles's author.

You can view the full analysis from the report here: CME

Loading ...